News & Analysis on Clinical Trial Services & Contract Research And Development
GlaxoSmithKline (GSK) publishes its fourth quarter earnings, which indicate a significant profit rise well ahead of industry predictions, with momentum building in its product pipeline of new drugs giving the company the go-ahead to look into...
NovaScreen BioSciences introduces a new side effect panel, which aims to improve procedures in identifying potential risk factors of drug candidates, by incorporating a broader range of receptor subtype assays, which target a broader range of...
Asia is emerging as a hot spot for low-cost medical device manufacturing as European drug companies pursue outsourcing options or relocate production to cut costs. This increasing Asian competition is alarming for European medical device companies...
Scientists have re-engineered a well-known antibiotic to counter drug resistance forming a new molecule in the process that could assist in treating hospital infections, which were previously resistant to common antibiotics putting its use under the...
Outsourcing-Pharma: Focus on Phase IIIB-IV research
A new book is available to help those involved in designing and conducting Phase IIIB and IV research gain maximum return on investment and deal effectively with post-marketing safety issues.
Supelco, a division of Sigma-Aldrich, introduces its HPLC Column, which offers improved retention power and resolution for difficult-to-separate analytes. The column becomes the latest in the Ascentis' family range, adding to the flexibility needed...
The industry trend in outsourcing opportunities shows no sign of weakening as contract researchers, easyRegDocs, introduced a new service that aims to simplify the process of completing clinical trial documentation, saving time and money.